1. Home
  2. OEC vs RLMD Comparison

OEC vs RLMD Comparison

Compare OEC & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orion S.A.

OEC

Orion S.A.

HOLD

Current Price

$7.11

Market Cap

359.9M

Sector

Industrials

ML Signal

HOLD

Logo Relmada Therapeutics Inc.

RLMD

Relmada Therapeutics Inc.

HOLD

Current Price

$3.77

Market Cap

319.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OEC
RLMD
Founded
1862
2004
Country
Luxembourg
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
359.9M
319.0M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
OEC
RLMD
Price
$7.11
$3.77
Analyst Decision
Sell
Strong Buy
Analyst Count
3
3
Target Price
$6.67
$9.00
AVG Volume (30 Days)
625.4K
564.3K
Earning Date
02-17-2026
03-26-2026
Dividend Yield
1.16%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,829,200,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.35
$0.24
52 Week High
$16.63
$5.12

Technical Indicators

Market Signals
Indicator
OEC
RLMD
Relative Strength Index (RSI) 57.30 48.58
Support Level $6.88 $3.71
Resistance Level $7.31 $4.35
Average True Range (ATR) 0.38 0.30
MACD 0.01 0.02
Stochastic Oscillator 59.13 60.35

Price Performance

Historical Comparison
OEC
RLMD

About OEC Orion S.A.

Orion SA is a manufacturer of carbon black products. Carbon black is a powdered form of carbon used to create the desired physical, electrical and optical qualities of various materials. The company's operating segments are Specialty Carbon Black and Rubber Carbon Black. It generates maximum revenue from the Rubber Carbon Black segment. Rubber Carbon Black segment is used in the reinforcement of rubber in tires and mechanical rubber goods. The Specialty Carbon Black segment is used as pigments and performance additives in coatings, polymers, printing and special applications. Geographically, it derives a majority of its revenue from Germany.

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

Share on Social Networks: